Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy in Diabetics | 3 | 2024 | 29 | 0.840 |
Why?
|
| Pregnancy | 19 | 2024 | 2605 | 0.620 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 285 | 0.540 |
Why?
|
| Legionellosis | 1 | 2015 | 4 | 0.530 |
Why?
|
| Hypertension | 2 | 2020 | 540 | 0.500 |
Why?
|
| Shock, Septic | 1 | 2015 | 78 | 0.480 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 73 | 0.480 |
Why?
|
| Dystocia | 1 | 2014 | 10 | 0.480 |
Why?
|
| Fetal Death | 1 | 2014 | 23 | 0.470 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2014 | 10 | 0.470 |
Why?
|
| Delivery, Obstetric | 2 | 2014 | 122 | 0.460 |
Why?
|
| Meningocele | 1 | 2013 | 7 | 0.440 |
Why?
|
| Sacrococcygeal Region | 1 | 2013 | 10 | 0.440 |
Why?
|
| Fractures, Bone | 1 | 2014 | 106 | 0.430 |
Why?
|
| Brain Injuries | 1 | 2014 | 157 | 0.420 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 167 | 0.390 |
Why?
|
| Pregnancy Complications | 4 | 2022 | 382 | 0.380 |
Why?
|
| Infant, Newborn | 7 | 2024 | 2767 | 0.340 |
Why?
|
| Diabetes, Gestational | 3 | 2016 | 52 | 0.330 |
Why?
|
| Postpartum Hemorrhage | 2 | 2018 | 34 | 0.260 |
Why?
|
| Adult | 15 | 2024 | 13384 | 0.260 |
Why?
|
| Trophoblasts | 2 | 2016 | 29 | 0.250 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2016 | 47 | 0.250 |
Why?
|
| Female | 19 | 2024 | 26668 | 0.250 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2024 | 40 | 0.240 |
Why?
|
| Placenta | 2 | 2020 | 132 | 0.210 |
Why?
|
| Insulin | 2 | 2016 | 458 | 0.210 |
Why?
|
| Pregnancy Outcome | 2 | 2022 | 237 | 0.200 |
Why?
|
| Hyperparathyroidism | 1 | 2022 | 31 | 0.200 |
Why?
|
| Telemedicine | 2 | 2020 | 459 | 0.190 |
Why?
|
| Thyroxine | 1 | 2021 | 47 | 0.180 |
Why?
|
| Hypothyroidism | 1 | 2021 | 54 | 0.180 |
Why?
|
| Humans | 19 | 2024 | 50251 | 0.180 |
Why?
|
| Prenatal Care | 3 | 2022 | 109 | 0.170 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 54 | 0.170 |
Why?
|
| Adiposity | 1 | 2019 | 133 | 0.160 |
Why?
|
| Labor Stage, Third | 1 | 2018 | 19 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2014 | 186 | 0.150 |
Why?
|
| Body Composition | 1 | 2019 | 320 | 0.150 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 77 | 0.150 |
Why?
|
| Serotonin | 2 | 2016 | 153 | 0.140 |
Why?
|
| Parents | 1 | 2019 | 314 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 486 | 0.140 |
Why?
|
| Receptor, Insulin | 1 | 2016 | 41 | 0.130 |
Why?
|
| Retrospective Studies | 4 | 2024 | 6172 | 0.130 |
Why?
|
| Dye Dilution Technique | 1 | 2014 | 18 | 0.120 |
Why?
|
| Episiotomy | 1 | 2014 | 6 | 0.120 |
Why?
|
| Molecular Chaperones | 1 | 2014 | 65 | 0.120 |
Why?
|
| Ultrasonography | 2 | 2013 | 437 | 0.120 |
Why?
|
| Pregnancy, High-Risk | 1 | 2014 | 60 | 0.120 |
Why?
|
| Promethazine | 1 | 2014 | 12 | 0.120 |
Why?
|
| Medical Records | 1 | 2014 | 86 | 0.120 |
Why?
|
| Ondansetron | 1 | 2014 | 13 | 0.120 |
Why?
|
| Pregnancy, Abdominal | 1 | 2013 | 10 | 0.110 |
Why?
|
| Antiemetics | 1 | 2014 | 32 | 0.110 |
Why?
|
| Blood Platelets | 1 | 2016 | 249 | 0.110 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2013 | 12 | 0.110 |
Why?
|
| Vomiting | 1 | 2014 | 75 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2014 | 349 | 0.110 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 108 | 0.110 |
Why?
|
| Counseling | 1 | 2014 | 131 | 0.110 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2013 | 18 | 0.110 |
Why?
|
| Rural Health Services | 1 | 2014 | 164 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2014 | 353 | 0.100 |
Why?
|
| Gestational Age | 4 | 2019 | 419 | 0.100 |
Why?
|
| Child Development | 1 | 2014 | 191 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2014 | 183 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 202 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2013 | 435 | 0.090 |
Why?
|
| Male | 5 | 2024 | 25483 | 0.090 |
Why?
|
| Professional Role | 1 | 2010 | 76 | 0.080 |
Why?
|
| Pharmacists | 1 | 2010 | 144 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 1542 | 0.070 |
Why?
|
| Arkansas | 3 | 2021 | 1962 | 0.060 |
Why?
|
| Vasoconstriction | 1 | 2005 | 55 | 0.060 |
Why?
|
| Depression | 1 | 2010 | 568 | 0.060 |
Why?
|
| Morphine | 1 | 2005 | 102 | 0.060 |
Why?
|
| Fetus | 1 | 2005 | 216 | 0.060 |
Why?
|
| Patient Education as Topic | 2 | 2021 | 312 | 0.050 |
Why?
|
| Time Factors | 2 | 2021 | 2911 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 6402 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 1557 | 0.050 |
Why?
|
| Patient Safety | 1 | 2021 | 102 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 4002 | 0.040 |
Why?
|
| Echocardiography | 1 | 2002 | 373 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 138 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2020 | 112 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 277 | 0.040 |
Why?
|
| Parturition | 1 | 2018 | 51 | 0.040 |
Why?
|
| Blood Volume | 1 | 2018 | 69 | 0.040 |
Why?
|
| Weight Gain | 1 | 2019 | 238 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2020 | 339 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1132 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2002 | 584 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2016 | 8 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 1257 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1397 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2018 | 654 | 0.030 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2014 | 10 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 2014 | 19 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 102 | 0.030 |
Why?
|
| Polyhydramnios | 1 | 2014 | 31 | 0.030 |
Why?
|
| Oligohydramnios | 1 | 2014 | 60 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 147 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 170 | 0.030 |
Why?
|
| Thrombosis | 1 | 2016 | 249 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2014 | 285 | 0.030 |
Why?
|
| Risk Factors | 1 | 2021 | 3608 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2013 | 187 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2013 | 258 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 687 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2019 | 3877 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 978 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2021 | 5186 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 176 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 606 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 1624 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 2379 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 704 | 0.020 |
Why?
|
| Prevalence | 1 | 2010 | 953 | 0.020 |
Why?
|
| Obesity | 1 | 2014 | 1106 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 12234 | 0.020 |
Why?
|
| Insect Bites and Stings | 1 | 2005 | 9 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2005 | 16 | 0.020 |
Why?
|
| Umbilical Arteries | 1 | 2005 | 22 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2005 | 43 | 0.020 |
Why?
|
| Analgesia, Obstetrical | 1 | 2005 | 26 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2005 | 35 | 0.020 |
Why?
|
| Heart Rate, Fetal | 1 | 2005 | 71 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 869 | 0.010 |
Why?
|